Hospital Stays Put Families at Risk of Superbug Infections, Study Finds
Family members of recently discharged patients face an increased risk of antibiotic-resistant infections, even if the patient was not diagnosed with the infection.
Tag: MRSA and multidrug resistant bacteria
All
Latest
Hospital Stays Put Families at Risk of Superbug Infections, Study Finds
Family members of recently discharged patients face an increased risk of antibiotic-resistant infections, even if the patient was not diagnosed with the infection.
Read More
Baxter Expands US Pharma Portfolio
Baxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
Read More
US Hospitals Slow to Adopt Newer Antibiotics for Highly Resistant Infections
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Read More
Liquid Crystal Nanoparticles Supercharge Antibiotics for Cystic Fibrosis
Researchers are developing liquid nanoparticles to bypass the barriers posed by thick mucus and frequent infections in cystic fibrosis lungs and prevent antimicrobial resistance.
Read More
Generative AI Model Designs New Superbug-fighting Antibiotics
Researchers have invented a new artificial intelligence model that can design billions of new antibiotic molecules that are inexpensive and easy to build in the laboratory.Â
Read More
AI Uncovers Promising Antibiotic to Fight Evasive Hospital Superbug
Scientists have used artificial intelligence to discover a new antibiotic that could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.
Read More
FDA Approves Manufacturing Site for C. difficile Preventative Therapy
Recipharm’s Vowst therapy is approved to prevent reinfection of C. difficile, which can infect patients with cystic fibrosis and other chronic diseases.
Read More
Long-forgotten Antibiotic Effective Against Multidrug-resistant Bacteria
The discovery of nourseothricin in the 1940s generated high hopes for it as a powerful agent against Gram-negative bacteria, but its development was dropped after proving toxic to kidneys. However, researchers are now taking another look.
Read More
FDA-approved Tuberculosis Regimen May Not Work for TB Meningitis
A US FDA-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis.
Read More
Probiotic Significantly Reduced S. aureus Colonization
The probiotic Bacillus subtilis markedly reduced S. aureus colonization in trial participants without harming their gut microbiota.
Read More
Pseudomonas Superbug Develops Fast Resistance to ‘Last Resort’ Antibiotic
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a “last resort” antibiotic.
Read More
Fast-growing Bacteria and Antibiotic Resistance
Fast-growing bacteria can develop antibiotic resistance through the higher expression of active ribosomes, according to a study published today in eLife.
Read More
New Class of Antibiotics Effective Against Drug-resistant Tuberculosis
A new class of antibiotics is highly effective against drug-resistant tuberculosis and, if validated, would represent a major advance in the treatment of TB.
Read More
COVID Pandemic May Be Accelerating Antimicrobial Resistance
Analysis of antimicrobial resistance in 271 US hospitals finds higher rates of antibiotic-resistant infections in both COVID patients and non-COVID patients admitted during the pandemic compared to pre-pandemic.
Read More
Antibiotic Overuse Likely in Patients with Severe COVID-19 Pneumonia
Only 21% of patients with severe pneumonia caused by SARS-CoV-2 have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics.
Read More
The Role of Staphylococcus Aureus In Cystic Fibrosis Lung Infections
Staphylococcus aureus can cause lung infections and is often present in the mucus and sputum of children with cystic fibrosis.
Read More
A Growing Body of Evidence Questions the Value of Anti-MRSA Therapy for Pneumonia
Anti-MRSA therapy in addition to standard pneumonia therapy does not improve mortality rates in pneumonia patients, a study published in JAMA Internal Medicine found.
Read More
Preventing MRSA Transmission from Therapy Dogs
Researchers say infection prevention protocols involving an antiseptic wash for therapy dogs could reduce the risks of MRSA transmission to pediatric cancer patients in a hospital setting.
Read MorePneumonia Drug Could Treat MRSA in Cystic Fibrosis
A new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.
Read More
Influenza-MRSA Co-Infection May Require Vancomycin Plus Second Antibiotic
The early addition of a second anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotic...
Read MoreInhaled Antibiotic to Fight MRSA in CF Patients Begins Ph3 Trial
A phase 3 trial is underway to examine the efficacy of Savara Pharmaceuticals’ AeroVanc inhalant for MRSA in patients with cystic fibrosis.
Read MoreE-cigarettes Boost Drug-Resistance of MRSA
Exposing MRSA to e-cigarette vapor boosted the pathogen’s drug-resistance, according to researchers at the VA San Diego Healthcare System and the University of California, San Diego.
Read More
Structure of MRSA Antibiotic-Resistant Protein Identified
Researchers uncovered the 3-D structure of the a protein that confers antibiotic resistance methicillin-resistant Staphylococcus aureus (MRSA). The find may allow researchers to develop an effective antibiotic against the bacterial superbug.
Read More
Universal Infection Prevention Strategy Significantly Reduces MRSA Infections in the ICU
Using germ-killing soap and ointment on all ICU patients can reduce bloodstream infections by up to 44% and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs.
Read More